Groot, ColinCicognola, ClaudiaBali, DivyaTriana‑Baltzer, GallenDage, Jeffrey L.Pontecorvo, Michael J.Kolb, Hartmuth C.Ossenkoppele, RikJanelidze, ShorenaHansson, Oskar2023-07-132023-07-132022-06-13Groot C, Cicognola C, Bali D, et al. Correction: Diagnostic and prognostic performance to detect Alzheimer's disease and clinical progression of a novel assay for plasma p-tau217. Alzheimers Res Ther. 2022;14(1):82. Published 2022 Jun 13. doi:10.1186/s13195-022-01023-6https://hdl.handle.net/1805/34350Erratum for: Diagnostic and prognostic performance to detect Alzheimer's disease and clinical progression of a novel assay for plasma p-tau217. Groot C, Cicognola C, Bali D, Triana-Baltzer G, Dage JL, Pontecorvo MJ, Kolb HC, Ossenkoppele R, Janelidze S, Hansson O. Alzheimers Res Ther. 2022 May 14;14(1):67. doi: 10.1186/s13195-022-01005-8. PMID: 35568889en-USAttribution 4.0 InternationalAlzheimer’s diseaseAssayMild cognitive impairmentPlasma biomarkersp-tauArticle